HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins

被引:333
作者
Buckley, Dennis L. [1 ]
Raina, Kanak [1 ]
Darricarrere, Nicole [2 ]
Hines, John [2 ]
Gustafson, Jeffrey L. [1 ]
Smith, Ian E. [4 ]
Miah, Aija H. [4 ]
Harling, John D. [4 ]
Crews, Craig M. [1 ,2 ,3 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
[3] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA
[4] GlaxoSmithKline, Prot Degradat Discovery Performance Unit, Stevenage SG1 2NY, Herts, England
基金
美国国家卫生研究院;
关键词
TARGETED DEGRADATION; PROTEASOME INHIBITOR; LIVING CELLS; CANCER; UBIQUITINATION; ACTIVATION; KNOCKDOWN; TOOL; ANTAGONISTS; EPOXOMICIN;
D O I
10.1021/acschembio.5b00442
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small molecule-induced protein degradation is an attractive strategy for the development of chemical probes. One method for inducing targeted protein degradation involves the use of PROTACs, heterobifunctional molecules that can recruit specific E3 ligases to a desired protein of interest. PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chemical probes or therapeutics. We report the design of a novel class of PROTACs that incorporate small molecule VHL ligands to successfully degrade HaloTag7 fusion proteins. These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties. Additionally, these HaloPROTACs are useful chemical genetic tools, due to their ability to chemically knock down widely used HaloTag7 fusion proteins in a general fashion.
引用
收藏
页码:1831 / 1837
页数:7
相关论文
共 39 条
[31]   Chemical genetic control of protein levels: Selective in vivo targeted degradation [J].
Schneekloth, JS ;
Fonseca, FN ;
Koldobskiy, M ;
Mandal, A ;
Deshaies, R ;
Sakamoto, K ;
Crews, CM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (12) :3748-3754
[32]   Broadly Applicable Methodology for the Rapid and Dosable Small Molecule-Mediated Regulation of Transcription Factors in Human Cells [J].
Shoulders, Matthew D. ;
Ryno, Lisa M. ;
Cooley, Christina B. ;
Kelly, Jeffery W. ;
Wiseman, R. Luke .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (22) :8129-8132
[33]   Stress-Independent Activation of XBP1s and/or ATF6 Reveals Three Functionally Diverse ER Proteostasis Environments [J].
Shoulders, Matthew D. ;
Ryno, Lisa M. ;
Genereux, Joseph C. ;
Moresco, James J. ;
Tu, Patricia G. ;
Wu, Chunlei ;
Yates, John R., III ;
Su, Andrew I. ;
Kelly, Jeffery W. ;
Wiseman, R. Luke .
CELL REPORTS, 2013, 3 (04) :1279-1292
[34]   Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology [J].
Sin, N ;
Kim, KB ;
Elofsson, M ;
Meng, LH ;
Auth, H ;
Kwok, BHB ;
Crews, CM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (15) :2283-2288
[35]   Identification of Hydrophobic Tags for the Degradation of Stabilized Proteins [J].
Tae, Hyun Seop ;
Sundberg, Thomas B. ;
Neklesa, Taavi K. ;
Noblin, Devin J. ;
Gustafson, Jeffrey L. ;
Roth, Anke G. ;
Raina, Kanak ;
Crews, Craig M. .
CHEMBIOCHEM, 2012, 13 (04) :538-541
[36]   BESTATIN, AN INHIBITOR OF AMINOPEPTIDASE-B, PRODUCED BY ACTINOMYCETES [J].
UMEZAWA, H ;
AOYAGI, T ;
SUDA, H ;
HAMADA, M ;
TAKEUCHI, T .
JOURNAL OF ANTIBIOTICS, 1976, 29 (01) :97-99
[37]   Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface [J].
Van Molle, Inge ;
Thomann, Andreas ;
Buckley, Dennis L. ;
So, Ernest C. ;
Lang, Steffen ;
Crews, Craig M. ;
Ciulli, Alessio .
CHEMISTRY & BIOLOGY, 2012, 19 (10) :1300-1312
[38]   IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis [J].
Varfolomeev, Eugene ;
Blankenship, John W. ;
Wayson, Sarah M. ;
Fedorova, Anna V. ;
Kayagaki, Nobuhiko ;
Garg, Parie ;
Zobel, Kerry ;
Dynek, Jasmin N. ;
Elliott, Linda O. ;
Wallweber, Heidi J. A. ;
Flygare, John A. ;
Fairbrother, Wayne J. ;
Deshayes, Kurt ;
Dixit, Vishva M. ;
Vucic, Domagoj .
CELL, 2007, 131 (04) :669-681
[39]   In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 [J].
Vassilev, LT ;
Vu, BT ;
Graves, B ;
Carvajal, D ;
Podlaski, F ;
Filipovic, Z ;
Kong, N ;
Kammlott, U ;
Lukacs, C ;
Klein, C ;
Fotouhi, N ;
Liu, EA .
SCIENCE, 2004, 303 (5659) :844-848